Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Morton

Showing results (911-920 of 1,110) with videos related to

Pageof 111
Sort By:
Cancer Research|September 18, 2004
Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cellsAdi Zipin, Mira Israeli-Amit, Tsipi Meshel, et al.
Journal of Molecular Biology|August 6, 2005
Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzilChristopher D Fleming, Sompop Bencharit, Carol C Edwards, et al.
Pediatric Blood & Cancer|February 9, 2008
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
BMJ Open|September 12, 2024
Acceptability and timing considerations when administering patient-reported outcome measures (PROMs) among people with chronic health conditions who are culturally and linguistically diverse (CALD): a qualitative study protocolJessica Nikolovski, Rachael L Morton, Rebecca Mercieca-Bebber, et al.
Clinical Chemistry|April 11, 2014
Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasisConnie G Chiu, Yoshitaka Nakamura, Kelly K Chong, et al.
Cancer Journal (Sudbury, Mass.)|March 20, 2002
Serum total gangliosides and TA90-IC levels: novel immunologic markers in colorectal cancerCarlos A Perez, Mepur H Ravindranath, Rishab K Gupta, et al.
Annals of Surgery|June 24, 2006
Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcomeJoseph Kim, Takuji Mori, Steven L Chen, et al.
Cancer Research|July 5, 2006
Estrogen receptor-alpha methylation predicts melanoma progressionTakuji Mori, Steve R Martinez, Steven J O'Day, et al.
Pediatric Blood & Cancer|July 20, 2007
Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Human Gene Therapy|February 29, 2024
Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of Hepatic Recombinant Adeno-Associated Virus-Mediated Gene TransferMark A Brimble, Christopher L Morton, Stephen M Winston, et al.
Pageof 111

Showing results (911-920 of 1,110) with videos related to

Sort By:
Pageof 111
Cancer Research|September 18, 2004
Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cellsAdi Zipin, Mira Israeli-Amit, Tsipi Meshel, et al.
Journal of Molecular Biology|August 6, 2005
Structural insights into drug processing by human carboxylesterase 1: tamoxifen, mevastatin, and inhibition by benzilChristopher D Fleming, Sompop Bencharit, Carol C Edwards, et al.
Pediatric Blood & Cancer|February 9, 2008
Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, Peter J Houghton, et al.
BMJ Open|September 12, 2024
Acceptability and timing considerations when administering patient-reported outcome measures (PROMs) among people with chronic health conditions who are culturally and linguistically diverse (CALD): a qualitative study protocolJessica Nikolovski, Rachael L Morton, Rebecca Mercieca-Bebber, et al.
Clinical Chemistry|April 11, 2014
Genome-wide characterization of circulating tumor cells identifies novel prognostic genomic alterations in systemic melanoma metastasisConnie G Chiu, Yoshitaka Nakamura, Kelly K Chong, et al.
Cancer Journal (Sudbury, Mass.)|March 20, 2002
Serum total gangliosides and TA90-IC levels: novel immunologic markers in colorectal cancerCarlos A Perez, Mepur H Ravindranath, Rishab K Gupta, et al.
Annals of Surgery|June 24, 2006
Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcomeJoseph Kim, Takuji Mori, Steven L Chen, et al.
Cancer Research|July 5, 2006
Estrogen receptor-alpha methylation predicts melanoma progressionTakuji Mori, Steve R Martinez, Steven J O'Day, et al.
Pediatric Blood & Cancer|July 20, 2007
Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediatric preclinical testing programPeter J Houghton, Christopher L Morton, E Anders Kolb, et al.
Human Gene Therapy|February 29, 2024
Pre-Existing Immunity to a Nucleic Acid Contaminant-Derived Antigen Mediates Transaminitis and Resultant Diminished Transgene Expression in a Mouse Model of Hepatic Recombinant Adeno-Associated Virus-Mediated Gene TransferMark A Brimble, Christopher L Morton, Stephen M Winston, et al.
Pageof 111